Prescription drug · ANDA
Prochlorperazine Edisylate NDC 55150-360
Prochlorperazine edisylate 5 mg/mL · Injection · Intramuscular, Intravenous · Eugia US LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55150-360-01 | 5515003600155150036001 | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-360-01) / 2 mL in 1 VIAL, MULTI-DOSEMarketed from Jul 14, 2022 | |
| 55150-360-25 | 5515003602555150036025 | 25 VIAL, MULTI-DOSE in 1 CARTON (55150-360-25) / 2 mL in 1 VIAL, MULTI-DOSEMarketed from Jul 14, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Prochlorperazine Edisylate
- Generic name (nonproprietary)
- prochlorperazine edisylate
- Active ingredients
- Prochlorperazine edisylate — 5 mg/mL
- Dosage form
- Injection
- Route
- Intramuscular, Intravenous
- Labeler
- Eugia US LLCNDC labeler code 55150
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 213873
- Marketing start
- Listing expires
- Other FDA classes
- Phenothiazines (Chemical structure)
- Identifiers
- Product ID 55150-360_5287e3a1-7470-4fd2-a9ea-acddf25ee83eSPL ID 5287e3a1-7470-4fd2-a9ea-acddf25ee83eSPL set ID 24358d03-d06d-4946-8ebd-a62bc15d33c0RxCUI 2102949UNII PG20W5VQZSUPC 0355150360017
- Pharmacologic class
- Phenothiazine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N455150036001followed by a unit qualifier and the quantityPackage 55150-0360-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE To control severe nausea and vomiting. For the treatment of schizophrenia. Prochlorperazine has not been shown effective in the management of behavioral complications in patients with mental retardation.
Excerpt only. Read the full label for complete information.
About NDC 55150-360
- What is NDC 55150-360?
- 55150-360 is the product NDC for Prochlorperazine Edisylate, Prochlorperazine edisylate 5 mg/mL injection, listed with the FDA by Eugia US LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Prochlorperazine Edisylate.
- What is the active ingredient?
- Prochlorperazine edisylate.
- Who is the labeler?
- Eugia US LLC, NDC labeler code 55150. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Prochlorperazine Edisylate?
- 17 other product NDCs are listed under this name. See all Prochlorperazine Edisylate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Prochlorperazine Edisylate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Prochlorperazine Edisylate | Prochlorperazine edisylate 5 mg/mL | InjectionIntramuscular, Intravenous | Caplin Steriles Limited | 65145-119 | 65145-0119-10 |
| Prochlorperazine Edisylate | Prochlorperazine edisylate 5 mg/mL | InjectionIntramuscular, Intravenous | Somerset Therapeutics, LLC | 70069-371 | 70069-0371-25 |
| prochlorperazine edisylate | Prochlorperazine edisylate 5 mg/mL | Injection, SolutionIntramuscular, Intravenous | Avenacy Inc. | 83634-778 | 83634-0778-02 |
| Prochlorperazine Edisylate | Prochlorperazine edisylate 5 mg/mL | InjectionIntramuscular, Intravenous | FOSUN PHARMA USA INC | 72266-204 | 72266-0204-10 |
| prochlorperazine edisylate | Prochlorperazine edisylate 5 mg/mL | InjectionIntramuscular, Intravenous | Amneal Pharmaceuticals LLC | 70121-1580 | 70121-1580-0570121-1580-07 |
| Prochlorperazine Edisylate | Prochlorperazine edisylate 5 mg/mL | InjectionIntramuscular, Intravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1558 | 51662-1558-03 |
| Prochlorperazine Edisylate | Prochlorperazine edisylate 5 mg/mL | InjectionIntramuscular, Intravenous | Cosette Pharmaceuticals, Inc. | 0713-0351 | 00713-0351-0900713-0351-25 |
| Prochlorperazine Edisylate | Prochlorperazine edisylate 5 mg/mL | InjectionIntramuscular, Intravenous | Sagent Pharmaceuticals | 25021-790 | 25021-0790-0225021-0790-03 |
| Prochlorperazine Edisylate | Prochlorperazine edisylate 5 mg/mL | InjectionIntramuscular, Intravenous | Gland Pharma Limited | 68083-435 | 68083-0435-1068083-0435-25 |
| Prochlorperazine Edisylate | Prochlorperazine edisylate 5 mg/mL | InjectionIntramuscular, Intravenous | Gland Pharma Limited | 68083-436 | 68083-0436-01 |